Antibody Drug Conjugates

Asia Pacific ADC trials grew consistently to reach over 35% share of global trials in 2022, from just over 25% in 2018, with Mainland China leading the trials.

Other relevant content

September 26, 2023 Report

Hemophilia - Global Clinical Trial Landscape

...

Download
February 5, 2020 Report

Accelerating Genetic Therapy Clinical Trials in Asia-Pacific

...

Download
September 13, 2023 Whitepaper

Cell and Gene Therapies Global Clinical Trial Landscape (2018-2022)

...

Download
August 3, 2020 Webinar

The Australian Solution to expediting your GMO clinical trial

Learn more about expediting your clinical trials in Australia with a focus on GMO products.

Watch
October 26, 2023 FAQ

Navigating the Landscape of CAR-T Research in China

...

Read More
September 13, 2023 FAQ

Unlocking the Future of Healthcare: Exploring Global Clinical Trends in Cell & Gene Therapy

...

Read More
April 3, 2023 FAQ

The Cell & Gene Therapy Clinical Trials Global Landscape

...

Read More
September 24, 2023 News

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

...

Read more Notification Icon
July 10, 2023 News

Novotech Presents Technical Session on Clinical Trial Success Factors at BIOPLUS-INTERPHEX KOREA…

...

Read more Notification Icon
May 26, 2023 News

Novotech Sponsors Oncology Summit with eChina Health and Expert Panel on Drug Development…

...

Read more Notification Icon
May 7-11, 2024 Events

American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting

Maryland

Read More
May 16-20, 2023 Events

American Society of Gene and Cell Therapy Annual Meeting

Los Angeles

Read More